文献速递糖尿病

量化1型糖尿病临床前阶段的β细胞功能

Quantifying beta cell function in the preclinical stages of type 1 diabetes.
PubMed 文献 · Diabetologia · 2023-09-15

本文综述1型糖尿病症状前阶段(1期和2期)β细胞功能进行性丧失的代谢变化,涉及胰岛素分泌与胰岛素敏感性,并讨论口服葡萄糖耐量试验等动态试验的代谢建模、风险指数及持续葡萄糖监测等微创 measures 的应用价值。

要点

  • 1型糖尿病3期前存在症状前期,胰岛自身免疫启动后功能性β细胞质量进行性丢失。
  • 1期无OGTT血糖谱改变,2期出现可测量的OGTT血糖谱变化。
  • 识别能纵向追踪β细胞功能变化的代谢试验对监测疾病进展和评估干预效果至关重要。

核心结论

  • 识别能纵向追踪β细胞功能变化的代谢试验对追踪1型糖尿病疾病进展和评估疾病修饰干预效果具有关键重要性。

研究设计与样本

  • 综述,描述1型糖尿病早期症状前阶段的代谢变化及可测量的结局指标。

主要发现

  • 1型糖尿病3期(临床有症状)之前存在症状前期,特征为胰岛自身免疫启动后功能性β细胞质量进行性丢失。
  • 症状前期包括1期(无OGTT血糖谱可测量变化)和2期(有OGTT血糖谱可测量变化)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinically symptomatic type 1 diabetes (stage 3 type 1 diabetes) is preceded by a pre-symptomatic phase, characterised by progressive loss of functional beta cell mass after the onset of islet autoimmunity, with (stage 2) or without (stage 1) measurable changes in glucose profile during an OGTT. Identifying metabolic tests that can longitudinally track changes in beta cell function is of pivotal importance to track disease progression and measure the effect of disease-modifying interventions. In this review we describe the metabolic changes that occur in the early pre-symptomatic stages of type 1 diabetes with respect to both insulin secretion and insulin sensitivity, as well as the measurable outcomes that can be derived from the available tests. We also discuss the use of metabolic modelling to identify insulin secretion and sensitivity, and the measurable changes during dynamic tests such as the OGTT. Finally, we review the role of risk indices and minimally invasive measures such as those derived from the use of continuous glucose monitoring.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Galderisi A, Carr ALJ, Martino M, et al. Quantifying beta cell function in the preclinical stages of type 1 diabetes. Diabetologia. 2023. PMID: 37712956. doi:10.1007/s00125-023-06011-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。